Parathyroid Gland Model for CKD Simulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional models fail to accurately simulate parathyroid gland (PTG) functionality, particularly in patients with health abnormalities like chronic kidney disease (CKD), limiting their ability to reflect complex ionized calcium regulatory system disruptions and provide effective treatment recommendations.
Innovation Solution
A computer-implemented method using a PTG functionality model that simulates PTG activity by receiving parameters such as calcium, vitamin D, and phosphorous concentrations, and a calcimimetic model to simulate the administration of calcimimetic compounds like cinacalcet, incorporating positive and negative feedback loops to determine parathyroid hormone (PTH) concentration and adaptation mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional models are used to simulate PTG functionality, then the model complexity is low and ease of manufacture is improved, but the manufacturing precision and reliability deteriorate because they fail to accurately reflect PTG functionality in patients with health abnormalities like CKD
Solution Approach 1:
The model is divided into multiple compartments representing different physiological spaces (blood, tissue, intracellular) and separate modules for calcium homeostasis, phosphate metabolism, and PTH regulation. This segmentation allows each component to be developed independently while maintaining overall accuracy in simulating PTG functionality in CKD patients.
Solution Approach 2:
The model incorporates disease-specific parameter modifications to reflect pathological states. Parameters such as GFR, phosphate clearance, and vitamin D activation rates are adjusted to match CKD patient physiology, enabling accurate simulation of secondary hyperparathyroidism while maintaining model structure simplicity.
2Device complexity
If conventional models are used to simulate PTG functionality, then the device complexity is low, but the measurement precision deteriorates because they cannot accurately capture disruptions in the ionized calcium regulatory system
Solution Approach 1:
The model implements multiple feedback loops to reproduce the ionized calcium regulatory system. Calcium-sensing receptors (CaSR) provide negative feedback to PTH secretion, vitamin D provides positive feedback to intestinal calcium absorption, and phosphate levels feedback to PTH production. These feedback mechanisms enable accurate measurement precision in simulating calcium homeostasis disruptions without excessive structural complexity.
Solution Approach 2:
The model employs nested compartments where intracellular processes are nested within tissue compartments, which are nested within the blood compartment. This hierarchical nesting allows the model to capture complex intracellular calcium signaling and mitochondrial dysfunction in CKD while maintaining an organized, manageable overall structure.
3Loss of time
If virtual models are used to evaluate PTG functionality and treatments, then the loss of time and resources is reduced compared to clinical studies, but the reliability may deteriorate if the models do not accurately reflect patient populations with health abnormalities
Solution Approach 1:
The model incorporates preliminary disease progression simulations that replicate the cascade of processes occurring in CKD patients before clinical intervention. By pre-programming the pathological changes in calcium-phosphate metabolism and PTH regulation, the model reliably predicts treatment outcomes without requiring actual patient recruitment and longitudinal monitoring.
Solution Approach 2:
The model uses parameter changes to reflect disease-specific physiological alterations in CKD patients, including reduced GFR, impaired phosphate excretion, and decreased vitamin D activation. These parameter adjustments ensure the virtual model accurately represents the target patient population, maintaining reliability while eliminating the time and resource costs of clinical studies.
Data Source
AI summary
The described technology may include processes to model parathyroid gland (PTG) functionality and/or calcimimetic administration to patients with a health abnormality that affects PTG function. In one embodiment, a method may include providing a PTG functionality model configured to simulate functionality of a PTG of a patient with a health abnormality affecting PTG function, the model may receive a parameters configured to regulate activity of calcium-sensing receptors (CaSR), the parameters may include a calcium concentration, a vitamin D concentration, and a phosphorous concentration, simulate CaSR expression and vitamin D receptor (VDR) expression via a positive feedback loop between the CaSR expression and the VDR expression, and suppression of the CaSR expression and the VDR expression by P, initiate at least one PTG adaptation based on the parameters, and determine a model output comprising a parathyroid hormone (PTH) concentration at one or more time intervals. Other embodiments are described.